Back to top

Image: Bigstock

New Strong Buy Stocks for April 6th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Harmony Gold Mining Company Limited(HMY - Free Report) : This company that engages in the exploration, extraction, and processing of gold has seen the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

MagnaChip Semiconductor Corporation (MX - Free Report) : This company that designs, manufactures, and sells analog and mixed-signal semiconductor platform solutionshas seen the Zacks Consensus Estimate for its current year earnings increasing 36.9% over the last 60 days.

Booz Allen Hamilton Holding Corporation (BAH - Free Report) : This company that provides management and technology consulting, engineering, analytics, digital, mission operations, and cyber solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.

CACI International Inc (CACI - Free Report) : This company that provides information solutions and serviceshas seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.

EMCOR Group, Inc. (EME - Free Report) : This company that provides electrical and mechanical construction, and facilities services has seen the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

EMCOR Group, Inc. Price and Consensus

 

EMCOR Group, Inc. Price and Consensus

EMCOR Group, Inc. price-consensus-chart | EMCOR Group, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>